Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg

Showing results (131-140 of 333) with videos related to

Pageof 34
Sort By:
Clinics and Research in Hepatology and Gastroenterology|February 6, 2022
Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosisLeonard Kaps, Katharina Hildebrand, Michael Nagel, et al.
Scientific Reports|January 24, 2025
A machine learning based algorithm accurately stages liver disease by quantification of arteriesZhengxin Li, Xin Sun, Zhimin Zhao, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2024
Short-term reduction of dietary gluten improves metabolic-dysfunction associated steatotic liver disease: A randomised, controlled proof-of-concept studyAngelo Armandi, Helena Bespaljko, Alexander Mang, et al.
Scientific Reports|April 5, 2023
NASHmap: clinical utility of a machine learning model to identify patients at risk of NASH in real-world settingsJörn M Schattenberg, Maria-Magdalena Balp, Brenda Reinhart, et al.
Hepatology Communications|February 5, 2022
Prevalence and Risk Factors of Advanced Liver Fibrosis in a Population-Based Study in GermanyYvonne Huber, Andreas Schulz, Irene Schmidtmann, et al.
Alimentary Pharmacology & Therapeutics|March 30, 2026
Review Article: Targeting Peroxisome Proliferator-Activated Receptors in Primary Biliary CholangitisJörn M Schattenberg, Jesus M Banales, Gideon Hirschfield, et al.
Plos One|July 27, 2021
Risk factors for poorer health literacy in patients with liver cirrhosisLeonard Kaps, Katharina Hildebrand, Michael Nagel, et al.
Alimentary Pharmacology & Therapeutics|April 6, 2026
Review Article: An Update on Non-Invasive Tests for Steatotic Liver Disease - Insights From the ESSENCE Phase 3 Trial and Longitudinal StudiesNaim Alkhouri, Naga Chalasani, Zobair Younossi, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2020
Association between diabetes mellitus and hepatic encephalopathy in patients with cirrhosisChristian Labenz, Michael Nagel, Wolfgang M Kremer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 3, 2025
A European Survey to Identify Challenges in the Management of Metabolic Dysfunction-Associated Steatotic Liver DiseaseLaurent Castera, William Alazawi, Elisabetta Bugianesi, et al.
Pageof 34

Showing results (131-140 of 333) with videos related to

Sort By:
Pageof 34
Clinics and Research in Hepatology and Gastroenterology|February 6, 2022
Validation of EncephalApp_Stroop as screening tool for the detection of minimal hepatic encephalopathy in German patients with liver cirrhosisLeonard Kaps, Katharina Hildebrand, Michael Nagel, et al.
Scientific Reports|January 24, 2025
A machine learning based algorithm accurately stages liver disease by quantification of arteriesZhengxin Li, Xin Sun, Zhimin Zhao, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2024
Short-term reduction of dietary gluten improves metabolic-dysfunction associated steatotic liver disease: A randomised, controlled proof-of-concept studyAngelo Armandi, Helena Bespaljko, Alexander Mang, et al.
Scientific Reports|April 5, 2023
NASHmap: clinical utility of a machine learning model to identify patients at risk of NASH in real-world settingsJörn M Schattenberg, Maria-Magdalena Balp, Brenda Reinhart, et al.
Hepatology Communications|February 5, 2022
Prevalence and Risk Factors of Advanced Liver Fibrosis in a Population-Based Study in GermanyYvonne Huber, Andreas Schulz, Irene Schmidtmann, et al.
Alimentary Pharmacology & Therapeutics|March 30, 2026
Review Article: Targeting Peroxisome Proliferator-Activated Receptors in Primary Biliary CholangitisJörn M Schattenberg, Jesus M Banales, Gideon Hirschfield, et al.
Plos One|July 27, 2021
Risk factors for poorer health literacy in patients with liver cirrhosisLeonard Kaps, Katharina Hildebrand, Michael Nagel, et al.
Alimentary Pharmacology & Therapeutics|April 6, 2026
Review Article: An Update on Non-Invasive Tests for Steatotic Liver Disease - Insights From the ESSENCE Phase 3 Trial and Longitudinal StudiesNaim Alkhouri, Naga Chalasani, Zobair Younossi, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2020
Association between diabetes mellitus and hepatic encephalopathy in patients with cirrhosisChristian Labenz, Michael Nagel, Wolfgang M Kremer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 3, 2025
A European Survey to Identify Challenges in the Management of Metabolic Dysfunction-Associated Steatotic Liver DiseaseLaurent Castera, William Alazawi, Elisabetta Bugianesi, et al.
Pageof 34